TP53INP2 and acute myeloid leukemia: Collectively, our findings uncover the oncogenic role of TP53INP2 in facilitating the high autophagy activity of NPM1-mutated AML and propose further insights into the autophagy-targeted therapy of this distinct leukemic entity.